Useful links
Unit of study_
PHAR5722: Endocrine, Renal and Cardiovascular
2024 unit information
This unit of study will cover the therapeutics of endocrine, renal and cardiovascular disorders including the pharmaceutical sciences that underpin such drug therapies. This unit will also include the epidemiology, pathophysiology and clinical features of endocrine, renal and cardiovascular disorders. Through the use of case‐based learning, students will participate in the interpretation, application and dissemination of pharmaceutical and pharmacotherapeutic concepts and knowledge. On completion of this unit of study students will be able to apply an understanding of the pharmaceutical sciences to optimising the drug and non‐drug therapy of patients with endocrine, renal and cardiovascular disorders. Interprofessional communication and the application of specialist knowledge to implementing pharmacist cognitive services such as clinical interventions and/or medication management review will also be explored.. Role‐plays will be used to develop students' communication skills for interaction between pharmacists and their clients (patients, doctors, other health professionals).
Unit details and rules
Managing faculty or University school:
Pharmacy
| Code | PHAR5722 |
|---|---|
| Academic unit | Pharmacy |
| Credit points | 6 |
|
Prerequisites:
?
|
PHAR5911 and PHAR5712 and PHAR5713 and PHAR5714 and PHAR5715 and PHAR5716 and PHAR5717 and PHAR5718 |
|---|---|
|
Corequisites:
?
|
PHAR5721 and PHAR5723 |
| Prohibitions:
?
|
None |
| Assumed knowledge:
?
|
None |
At the completion of this unit, you should be able to:
- LO1. critically examine scientific evidence, in order to evaluate safety, quality, efficacy and cost effectiveness of prescriptions, complementary medicines and other orders to arrive at evidence-based conclusions relevant to patient care.
- LO2. demonstrate an understanding of the body as a complex adaptive biological system and outline physiology and patho-physiology associated with disease states of the endocrine, renal and cardiovascular systems.
- LO3. demonstrate a working understanding of fundamental concepts and techniques of the sciences underpinning drug delivery, drug action and therapeutics.
- LO4. demonstrate an understanding of the pharmacological mechanisms of action and the properties drugs display as biologically active molecules in the treatment of endocrine, renal and cardiovascular disorders.
- LO5. demonstrate an understanding of pharmaceutical and physical factors impacting on therapeutic efficacy.
- LO6. apply an understanding of basic and applied sciences to the management and solution of pharmaceutical and/or clinical problems including the metabolism and enzymatic degradation (pharmacodynamics and pharmacokinetics) of drugs in the human body.
- LO7. communicate effectively with patients, families, carers and other health care professionals; providing appropriate advice and counselling about prescribed or over-the-counter medicines for endocrine, renal and/or cardiovascular disorders.
- LO8. apply a systematic clinical reasoning process to address a range of health and drug-related problems that present in pharmacy in order to provide appropriate pharmacy cognitive services in the areas of endocrine, renal and cardiovascular disorders.
- LO9. apply appropriate clinical reasoning skills to generate a medication review, including communication with the physician, according to principles of practice and adequate patient care.
Unit availability
This section lists the session, attendance modes and locations the unit is available in. There is a unit outline for each of the unit availabilities, which gives you information about the unit including assessment details and a schedule of weekly activities.
The outline is published 2 weeks before the first day of teaching. You can look at previous outlines for a guide to the details of a unit.
Modes of attendance (MoA)
This refers to the Mode of attendance (MoA) for the unit as it appears when you’re selecting your units in Sydney Student. Find more information about modes of attendance on our website.
